EGF and breast neoplasm: The phosphorylation of these substrate candidates induced by EGF stimulation (a known PTK6 stimulus) remained unchanged following treatment with PTK6 inhibitors in breast tumor cells MDA-MB-231 and HCC1954 (data not shown), casting a doubt if they are physiological PTK6 substrates in tumor cells.